BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W, Smit F, Crunelle CL, Swets M, Schoevers RA. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend. 2012;122:11-19. [PMID: 22209385 DOI: 10.1016/j.drugalcdep.2011.12.007] [Cited by in Crossref: 241] [Cited by in F6Publishing: 192] [Article Influence: 21.9] [Reference Citation Analysis]
Number Citing Articles
1 Galéra C, Pingault J, Fombonne E, Michel G, Lagarde E, Bouvard M, Melchior M. Attention Problems in Childhood and Adult Substance Use. The Journal of Pediatrics 2013;163:1677-1683.e1. [DOI: 10.1016/j.jpeds.2013.07.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
2 Jordan CJ, Harvey RC, Baskin BB, Dwoskin LP, Kantak KM. Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments. Drug Alcohol Depend 2014;140:25-32. [PMID: 24811203 DOI: 10.1016/j.drugalcdep.2014.04.020] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
3 Fluyau D, Revadigar N, Pierre CG. Systematic Review and Meta-Analysis: Treatment of Substance Use Disorder in Attention Deficit Hyperactivity Disorder. Am J Addict 2021;30:110-21. [PMID: 33289928 DOI: 10.1111/ajad.13133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Karaca S, Saleh A, Canan F, Potenza MN. Comorbidity between Behavioral Addictions and Attention Deficit/Hyperactivity Disorder: a Systematic Review. Int J Ment Health Addiction 2017;15:701-24. [DOI: 10.1007/s11469-016-9660-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
5 Castells X, Blanco-Silvente L, Cunill R. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev 2018;8:CD007813. [PMID: 30091808 DOI: 10.1002/14651858.CD007813.pub3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
6 Daigre C, Roncero C, Rodríguez-cintas L, Ortega L, Lligoña A, Fuentes S, Pérez-pazos J, Martínez-luna N, Casas M. Adult ADHD Screening in Alcohol-Dependent Patients Using the Wender–Utah Rating Scale and the Adult ADHD Self-Report Scale. J Atten Disord 2015;19:328-34. [DOI: 10.1177/1087054714529819] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
7 Fiksdal Abel K, Ravndal E, Clausen T, Bramness JG. Attention Deficit Hyperactivity Disorder Symptoms are Common in Patients in Opioid Maintenance Treatment. Eur Addict Res 2017;23:298-305. [PMID: 29320768 DOI: 10.1159/000484240] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 Havemann-Reinecke U, Hoch E, Preuss UW, Kiefer F, Batra A, Gerlinger G, Hauth I. [On the legalization debate of non-medical cannabis consumption : Position paper of the German Association for Psychiatry, Psychotherapy and Psychosomatics]. Nervenarzt 2017;88:291-8. [PMID: 27981374 DOI: 10.1007/s00115-016-0248-0] [Cited by in Crossref: 6] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lucet C, Olié JP. [Addictive behaviors: Clinical facts]. Bull Acad Natl Med 2020;204:551-60. [PMID: 32296241 DOI: 10.1016/j.banm.2020.04.005] [Reference Citation Analysis]
10 van Hagen LJ, de Waal MM, Christ C, Dekker JJM, Goudriaan AE. Patient Characteristics Predicting Abstinence in Substance Use Disorder Patients With Comorbid Mental Disorders. J Dual Diagn 2019;15:312-23. [PMID: 31566115 DOI: 10.1080/15504263.2019.1667043] [Reference Citation Analysis]
11 Jansen M. NPs' use of guidelines to diagnose and treat childhood ADHD. Nurse Pract 2019;44:37-42. [PMID: 31211737 DOI: 10.1097/01.NPR.0000559845.76249.48] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Hulka LM, Vonmoos M, Preller KH, Baumgartner MR, Seifritz E, Gamma A, Quednow BB. Changes in cocaine consumption are associated with fluctuations in self-reported impulsivity and gambling decision-making. Psychol Med 2015;45:3097-110. [PMID: 26081043 DOI: 10.1017/S0033291715001063] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 5.9] [Reference Citation Analysis]
13 Mahadevan J, Kandasamy A, Benegal V. Situating adult attention-deficit/hyperactivity disorder in the externalizing spectrum: Etiological, diagnostic, and treatment considerations. Indian J Psychiatry 2019;61:3-12. [PMID: 30745648 DOI: 10.4103/psychiatry.IndianJPsychiatry_549_18] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Nardo T, Batchelor J, Berry J, Francis H, Jafar D, Borchard T. Cognitive Remediation as an Adjunct Treatment for Substance Use Disorders: A Systematic Review. Neuropsychol Rev 2021. [PMID: 33871785 DOI: 10.1007/s11065-021-09506-3] [Reference Citation Analysis]
15 Karlstad Ø, Furu K, Skurtveit S, Selmer R. Prescribing of Drugs for Attention-Deficit Hyperactivity Disorder in Opioid Maintenance Treatment Patients in Norway. Eur Addict Res 2014;20:59-65. [DOI: 10.1159/000353969] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
16 Ottosen C, Petersen L, Larsen JT, Dalsgaard S. Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder. J Am Acad Child Adolesc Psychiatry 2016;55:227-34.e4. [PMID: 26903256 DOI: 10.1016/j.jaac.2015.12.010] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 4.9] [Reference Citation Analysis]
17 Allanson F, Pestell C, Gignac GE, Yeo YX, Weinborn M. Neuropsychological Predictors of Outcome Following Traumatic Brain Injury in Adults: a Meta-Analysis. Neuropsychol Rev 2017;27:187-201. [DOI: 10.1007/s11065-017-9353-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
18 Miranda A, Colomer C, Berenguer C, Roselló R, Roselló B. Substance use in young adults with ADHD: Comorbidity and symptoms of inattention and hyperactivity/impulsivity. Int J Clin Health Psychol 2016;16:157-65. [PMID: 30487859 DOI: 10.1016/j.ijchp.2015.09.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
19 Nehlin C, Nyberg F, Öster C. The Patient’s Perspective on the Link Between ADHD and Substance Use: A Qualitative Interview Study. J Atten Disord 2015;19:343-50. [DOI: 10.1177/1087054714554618] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
20 Manni C, Cipollone G, Pallucchini A, Maremmani AGI, Perugi G, Maremmani I. Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder/Cocaine Use Disorder) Patients Treated with Medications for ADHD. Int J Environ Res Public Health 2019;16:E3911. [PMID: 31618876 DOI: 10.3390/ijerph16203911] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Konstenius M, Jayaram-Lindström N, Guterstam J, Beck O, Philips B, Franck J. Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial. Addiction 2014;109:440-9. [PMID: 24118269 DOI: 10.1111/add.12369] [Cited by in Crossref: 78] [Cited by in F6Publishing: 63] [Article Influence: 8.7] [Reference Citation Analysis]
22 Cook J, Lloyd-jones M, Arunogiri S, Ogden E, Bonomo Y. Managing attention deficit hyperactivity disorder in adults using illicit psychostimulants: A systematic review. Aust N Z J Psychiatry 2017;51:876-85. [DOI: 10.1177/0004867417714878] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Keith JR, Rapgay L, Theodore D, Schwartz JM, Ross JL. An assessment of an automated EEG biofeedback system for attention deficits in a substance use disorders residential treatment setting. Psychol Addict Behav 2015;29:17-25. [PMID: 25180558 DOI: 10.1037/adb0000016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
24 van de Glind G, Van Emmerik-van Oortmerssen K, Carpentier PJ, Levin FR, Koeter MW, Barta C, Kaye S, Skutle A, Franck J, Konstenius M, Bu ET, Moggi F, Dom G, Demetrovics Z, Fatséas M, Schillinger A, Kapitány-Fövény M, Verspreet S, Seitz A, Johnson B, Faraone SV, Ramos-Quiroga JA, Allsop S, Carruthers S, Schoevers RA, van den Brink W; Iasp Research Group. The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population. Int J Methods Psychiatr Res 2013;22:232-44. [PMID: 24022983 DOI: 10.1002/mpr.1397] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
25 Treur JL, Willemsen G, Bartels M, Geels LM, van Beek JH, Huppertz C, van Beijsterveldt CE, Boomsma DI, Vink JM. Smoking During Adolescence as a Risk Factor for Attention Problems. Biological Psychiatry 2015;78:656-63. [DOI: 10.1016/j.biopsych.2014.06.019] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
26 Helverschou SB, Brunvold AR, Arnevik EA. Treating Patients With Co-occurring Autism Spectrum Disorder and Substance Use Disorder: A Clinical Explorative Study. Subst Abuse 2019;13:1178221819843291. [PMID: 31024216 DOI: 10.1177/1178221819843291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Özgen H, Spijkerman R, Noack M, Holtmann M, Schellekens A, Dalsgaard S, van den Brink W, Hendriks V. Treatment of Adolescents with Concurrent Substance Use Disorder and Attention-Deficit/Hyperactivity Disorder: A Systematic Review. J Clin Med 2021;10:3908. [PMID: 34501355 DOI: 10.3390/jcm10173908] [Reference Citation Analysis]
28 Mitchell JT, Weisner TS, Jensen PS, Murray DW, Molina BSG, Arnold LE, Hechtman L, Swanson JM, Hinshaw SP, Victor EC, Kollins SH, Wells KC, Belendiuk KA, Blonde A, Nguyen C, Ambriz L, Nguyen JL. How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning. J Atten Disord 2018;22:49S-60S. [PMID: 28166690 DOI: 10.1177/1087054716685842] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
29 Carrellas N, Wilens TE, Anselmo R. Treatment of Comorbid Substance Use Disorders and ADHD in Youth. Curr Treat Options Psych 2016;3:15-27. [DOI: 10.1007/s40501-016-0072-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
30 Schoenmacker GH, Groenman AP, Sokolova E, Oosterlaan J, Rommelse N, Roeyers H, Oades RD, Faraone SV, Franke B, Heskes T, Arias Vasquez A, Claassen T, Buitelaar JK. Role of conduct problems in the relation between Attention-Deficit Hyperactivity disorder, substance use, and gaming. Eur Neuropsychopharmacol 2020;30:102-13. [PMID: 30292416 DOI: 10.1016/j.euroneuro.2018.06.003] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
31 Braatveit KJ, Torsheim T, Hove O. The Prevalence and Characteristics of Intellectual and Borderline Intellectual Disabilities in a Sample of Inpatients with Substance Use Disorders: Preliminary Clinical Results. Journal of Mental Health Research in Intellectual Disabilities 2018;11:203-20. [DOI: 10.1080/19315864.2018.1469701] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Luderer M, Sick C, Kaplan-wickel N, Reinhard I, Richter A, Kiefer F, Weber T. Prevalence Estimates of ADHD in a Sample of Inpatients With Alcohol Dependence. J Atten Disord 2020;24:2072-83. [DOI: 10.1177/1087054717750272] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
33 Notzon DP, Pavlicova M, Glass A, Mariani JJ, Mahony AL, Brooks DJ, Levin FR. ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders. J Atten Disord 2020;24:1487-92. [PMID: 27033880 DOI: 10.1177/1087054716640109] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
34 Zaso MJ, Park A, Antshel KM. Treatments for Adolescents With Comorbid ADHD and Substance Use Disorder: A Systematic Review. J Atten Disord 2020;24:1215-26. [PMID: 25655767 DOI: 10.1177/1087054715569280] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
35 Crunelle CL, Veltman DJ, van Emmerik-van Oortmerssen K, Booij J, van den Brink W. Impulsivity in adult ADHD patients with and without cocaine dependence. Drug and Alcohol Dependence 2013;129:18-24. [DOI: 10.1016/j.drugalcdep.2012.09.006] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
36 Chamberlain SR, Ioannidis K, Leppink EW, Niaz F, Redden SA, Grant JE. ADHD symptoms in non-treatment seeking young adults: relationship with other forms of impulsivity. CNS Spectr 2017;22:22-30. [PMID: 27680974 DOI: 10.1017/S1092852915000875] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
37 van de Glind G, van den Brink W, Koeter MW, Carpentier PJ, van Emmerik-van Oortmerssen K, Kaye S, Skutle A, Bu ET, Franck J, Konstenius M, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitány-Fövény M, Fatséas M, Auriacombe M, Schillinger A, Seitz A, Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Barta C, Schoevers RA, Levin FR; IASP Research Group. Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug Alcohol Depend 2013;132:587-96. [PMID: 23660242 DOI: 10.1016/j.drugalcdep.2013.04.010] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 8.1] [Reference Citation Analysis]
38 Azeredo A, Moreira D, Barbosa F. ADHD, CD, and ODD: Systematic review of genetic and environmental risk factors. Research in Developmental Disabilities 2018;82:10-9. [DOI: 10.1016/j.ridd.2017.12.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
39 Iqbal MN, Levin CJ, Levin FR. Treatment for Substance Use Disorder With Co-Occurring Mental Illness. Focus (Am Psychiatr Publ) 2019;17:88-97. [PMID: 31975963 DOI: 10.1176/appi.focus.20180042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
40 Jokiranta-Olkoniemi E, Cheslack-Postava K, Joelsson P, Suominen A, Brown AS, Sourander A. Attention-deficit/hyperactivity disorder and risk for psychiatric and neurodevelopmental disorders in siblings. Psychol Med 2019;49:84-91. [PMID: 29607791 DOI: 10.1017/S0033291718000521] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
41 Cunill R, Castells X, Tobias A, Capellà D. Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence. J Psychopharmacol 2015;29:15-23. [PMID: 25142405 DOI: 10.1177/0269881114544777] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
42 Breeksema JJ, Niemeijer AR, Krediet E, Vermetten E, Schoevers RA. Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies. CNS Drugs 2020;34:925-46. [PMID: 32803732 DOI: 10.1007/s40263-020-00748-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
43 van der Burg D, Crunelle CL, Matthys F, van den Brink W. Diagnosis and treatment of patients with comorbid substance use disorder and adult attention-deficit and hyperactivity disorder: a review of recent publications. Curr Opin Psychiatry 2019;32:300-6. [PMID: 31008730 DOI: 10.1097/YCO.0000000000000513] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
44 Ganesh S, Kandasamy A, Sahayaraj US, Benegal V. Adult Attention Deficit Hyperactivity Disorder in Patients with Substance Use Disorders: A Study from Southern India. Indian J Psychol Med 2017;39:59-62. [PMID: 28250560 DOI: 10.4103/0253-7176.198945] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
45 Vold JH, Aas C, Skurtveit S, Odsbu I, Chalabianloo F, Halmøy A, Johansson KA, Fadnes LT. Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017. BMC Psychiatry 2020;20:119. [PMID: 32164615 DOI: 10.1186/s12888-020-02526-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
46 Eme R. Male adolescent substance use disorder and attention-deficit hyperactivity disorder: a review of the literature. ISRN Addict 2013;2013:815096. [PMID: 25969828 DOI: 10.1155/2013/815096] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
47 Zulauf CA, Sprich SE, Safren SA, Wilens TE. The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders. Curr Psychiatry Rep 2014;16:436. [PMID: 24526271 DOI: 10.1007/s11920-013-0436-6] [Cited by in Crossref: 75] [Cited by in F6Publishing: 50] [Article Influence: 9.4] [Reference Citation Analysis]
48 Zamboni L, Marchetti P, Congiu A, Giordano R, Fusina F, Carli S, Centoni F, Verlato G, Lugoboni F. ASRS Questionnaire and Tobacco Use: Not Just a Cigarette. A Screening Study in an Italian Young Adult Sample. Int J Environ Res Public Health 2021;18:2920. [PMID: 33809225 DOI: 10.3390/ijerph18062920] [Reference Citation Analysis]
49 Tanner-Smith EE, Cronce JM. Introduction to the Special Issue on Meta-Analyses and Systematic Reviews. Alcohol Alcohol 2021:agab068. [PMID: 34625798 DOI: 10.1093/alcalc/agab068] [Reference Citation Analysis]
50 Young JT, Carruthers S, Kaye S, Allsop S, Gilsenan J, Degenhardt L, van de Glind G, van den Brink W, Preen D. Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults. Drug Alcohol Rev. 2015;34:683-693. [PMID: 25790353 DOI: 10.1111/dar.12249] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
51 Itoh M, Yonemoto T, Ueno F, Iwahara C, Yumoto Y, Nakayama H, Maesato H, Kimura M, Matsushita S. Influence of Comorbid Psychiatric Disorders on the Risk of Development of Alcohol Dependence by Genetic Variations of ALDH2 and ADH1B. Alcohol Clin Exp Res 2020;44:2275-82. [PMID: 32890420 DOI: 10.1111/acer.14450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Young S, Sedgwick O, Fridman M, Gudjonsson G, Hodgkins P, Lantigua M, González RA. Co-morbid psychiatric disorders among incarcerated ADHD populations: a meta-analysis. Psychol Med 2015;45:2499-510. [PMID: 25857258 DOI: 10.1017/S0033291715000598] [Cited by in Crossref: 43] [Cited by in F6Publishing: 13] [Article Influence: 6.1] [Reference Citation Analysis]
53 Richter M, Spangenberg H, Ramklint M, Ramirez A. The clinical relevance of asking young psychiatric patients about childhood ADHD symptoms. Nord J Psychiatry 2020;74:23-9. [PMID: 31556784 DOI: 10.1080/08039488.2019.1667427] [Reference Citation Analysis]
54 Luderer M, Kiefer F, Reif A, Moggi F. ADHS bei erwachsenen Patienten mit Substanzkonsumstörungen. Nervenarzt 2019;90:926-31. [DOI: 10.1007/s00115-019-0779-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
55 Ayhan Y, Gürel ŞC, Karaca Ö, Zoto T, Hayran M, Babaoğlu M, Yaşar Ü, Bozkurt A, Dilbaz N, Uluğ BD, Demir B. Association between ADH1C and ALDH2 polymorphisms and alcoholism in a Turkish sample. Nord J Psychiatry 2015;69:233-9. [PMID: 25372623 DOI: 10.3109/08039488.2014.972450] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
56 Marmet S, Studer J, Lemoine M, Grazioli VS, Bertholet N, Gmel G. Reconsidering the associations between self-reported alcohol use disorder and mental health problems in the light of co-occurring addictions in young Swiss men. PLoS One 2019;14:e0222806. [PMID: 31568530 DOI: 10.1371/journal.pone.0222806] [Reference Citation Analysis]
57 Crunelle CL, van den Brink W, Veltman DJ, van Emmerik-van Oortmerssen K, Dom G, Schoevers RA, Booij J. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence. European Neuropsychopharmacology 2013;23:1714-23. [DOI: 10.1016/j.euroneuro.2013.05.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
58 Ballon N, Brunault P, Cortese S. Sensation seeking and cocaine dependence in adults with reported childhood ADHD. J Atten Disord 2015;19:335-42. [PMID: 25085652 DOI: 10.1177/1087054714543651] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
59 Kedem S, Yust-Katz S, Carter D, Levi Z, Kedem R, Dickstein A, Daher S, Katz LH. Attention deficit hyperactivity disorder and gastrointestinal morbidity in a large cohort of young adults. World J Gastroenterol 2020; 26(42): 6626-6637 [PMID: 33268951 DOI: 10.3748/wjg.v26.i42.6626] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Nigg JT. Attention-deficit/hyperactivity disorder and adverse health outcomes. Clin Psychol Rev. 2013;33:215-228. [PMID: 23298633 DOI: 10.1016/j.cpr.2012.11.005] [Cited by in Crossref: 190] [Cited by in F6Publishing: 151] [Article Influence: 19.0] [Reference Citation Analysis]
61 Mangerud WL, Bjerkeset O, Holmen TL, Lydersen S, Indredavik MS. Smoking, alcohol consumption, and drug use among adolescents with psychiatric disorders compared with a population based sample. J Adolesc. 2014;37:1189-1199. [PMID: 25190498 DOI: 10.1016/j.adolescence.2014.08.007] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
62 Matthys F, Stes S, van den Brink W, Joostens P, Möbius D, Tremmery S, Sabbe B. Guideline for Screening, Diagnosis and Treatment of ADHD in Adults with Substance Use Disorders. Int J Ment Health Addiction 2014;12:629-47. [DOI: 10.1007/s11469-014-9496-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
63 Capusan AJ, Bendtsen P, Marteinsdottir I, Kuja-Halkola R, Larsson H. Genetic and environmental contributions to the association between attention deficit hyperactivity disorder and alcohol dependence in adulthood: A large population-based twin study. Am J Med Genet B Neuropsychiatr Genet 2015;168:414-22. [PMID: 25711682 DOI: 10.1002/ajmg.b.32300] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
64 van de Glind G, Konstenius M, Koeter MWJ, van Emmerik-van Oortmerssen K, Carpentier PJ, Kaye S, Degenhardt L, Skutle A, Franck J, Bu ET, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitány-Fövény M, Fatséas M, Auriacombe M, Schillinger A, Møller M, Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Schoevers RA, Wallhed S, Barta C, Alleman P, Levin FR, van den Brink W; IASP Research Group. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug Alcohol Depend 2014;134:158-66. [PMID: 24156882 DOI: 10.1016/j.drugalcdep.2013.09.026] [Cited by in Crossref: 91] [Cited by in F6Publishing: 79] [Article Influence: 10.1] [Reference Citation Analysis]
65 Cardullo S, Gómez Pérez LJ, Cuppone D, Sarlo M, Cellini N, Terraneo A, Gallimberti L, Madeo G. A Retrospective Comparative Study in Patients With Cocaine Use Disorder Comorbid With Attention Deficit Hyperactivity Disorder Undergoing an rTMS Protocol Treatment. Front Psychiatry 2021;12:659527. [PMID: 33841218 DOI: 10.3389/fpsyt.2021.659527] [Reference Citation Analysis]
66 Wilens TE, Morrison NR. Substance-use disorders in adolescents and adults with ADHD: focus on treatment. Neuropsychiatry (London) 2012;2:301-12. [PMID: 23105949 DOI: 10.2217/npy.12.39] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
67 Groenman AP, Schweren LJ, Dietrich A, Hoekstra PJ. An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder. Expert Opin Drug Saf 2017;16:455-64. [PMID: 28277842 DOI: 10.1080/14740338.2017.1301928] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
68 Young S, Sedgwick O. Attention deficit hyperactivity disorder and substance misuse: an evaluation of causal hypotheses and treatment considerations. Expert Review of Neurotherapeutics 2015;15:1005-14. [DOI: 10.1586/14737175.2015.1059756] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
69 Young S, González RA, Fridman M, Hodgkins P, Kim K, Gudjonsson GH. The economic consequences of attention-deficit hyperactivity disorder in the Scottish prison system. BMC Psychiatry 2018;18:210. [PMID: 29940897 DOI: 10.1186/s12888-018-1792-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
70 Luderer M, Kaplan-wickel N, Sick C, Richter A, Reinhard I, Kiefer F, Weber T. ADHS-Screening bei Alkoholabhängigen: Psychometrische Eigenschaften der ADHS-Selbstbeurteilungsskala (ADHS-SB) und der Wender-Utah-Rating-Scale Kurzform (WURS‑k). Nervenarzt 2019;90:1156-61. [DOI: 10.1007/s00115-019-0706-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
71 Brandt L, Fischer G. Adult ADHD Is Associated With Gambling Severity and Psychiatric Comorbidity Among Treatment-Seeking Problem Gamblers. J Atten Disord 2017;23:1383-95. [DOI: 10.1177/1087054717690232] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
72 Schoofs N, Heinz A. Pathologisches Spielen: Impulskontrollstörung, Sucht oder Zwang? Nervenarzt 2013;84:629-34. [DOI: 10.1007/s00115-012-3581-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
73 van Emmerik-van Oortmerssen K, Vedel E, Koeter MW, de Bruijn K, Dekker JJ, van den Brink W, Schoevers RA. Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial. BMC Psychiatry 2013;13:132. [PMID: 23663651 DOI: 10.1186/1471-244X-13-132] [Cited by in Crossref: 22] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
74 El Archi S, Cortese S, Ballon N, Réveillère C, De Luca A, Barrault S, Brunault P. Negative Affectivity and Emotion Dysregulation as Mediators between ADHD and Disordered Eating: A Systematic Review. Nutrients 2020;12:E3292. [PMID: 33121125 DOI: 10.3390/nu12113292] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
75 Luderer M, Kaplan-wickel N, Richter A, Reinhard I, Kiefer F, Weber T. Screening for adult attention-deficit/hyperactivity disorder in alcohol dependent patients: Underreporting of ADHD symptoms in self-report scales. Drug and Alcohol Dependence 2019;195:52-8. [DOI: 10.1016/j.drugalcdep.2018.11.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
76 van Emmerik-van Oortmerssen K, van de Glind G, Koeter MW, Allsop S, Auriacombe M, Barta C, Bu ET, Burren Y, Carpentier PJ, Carruthers S, Casas M, Demetrovics Z, Dom G, Faraone SV, Fatseas M, Franck J, Johnson B, Kapitány-Fövény M, Kaye S, Konstenius M, Levin FR, Moggi F, Møller M, Ramos-Quiroga JA, Schillinger A, Skutle A, Verspreet S, van den Brink W, Schoevers RA; IASP research group. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. Addiction 2014;109:262-72. [PMID: 24118292 DOI: 10.1111/add.12370] [Cited by in Crossref: 82] [Cited by in F6Publishing: 66] [Article Influence: 9.1] [Reference Citation Analysis]
77 Helene Bergly T, Julius Sømhovd M. The Relation Between ADHD Medication and Mild Cognitive Impairment, as Assessed by the Montreal Cognitive Assessment (MoCA), in Patients Entering Substance Use Disorder Inpatient Treatment. Journal of Dual Diagnosis 2018;14:228-36. [DOI: 10.1080/15504263.2018.1496305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
78 Baingana F, al'Absi M, Becker AE, Pringle B. Global research challenges and opportunities for mental health and substance-use disorders. Nature 2015;527:S172-7. [PMID: 26580324 DOI: 10.1038/nature16032] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 7.1] [Reference Citation Analysis]
79 Işık Ü, Çokünlü Y, Şimşek F, Demirel B, Kılıç F, Demirdaş A, Eren İ. Autistic Traits in Men With Substance Use Disorder. J Nerv Ment Dis 2020;208:505-9. [PMID: 32195775 DOI: 10.1097/NMD.0000000000001165] [Reference Citation Analysis]
80 Martins-Silva T, Vaz JDS, Hutz MH, Salatino-Oliveira A, Genro JP, Hartwig FP, Moreira-Maia CR, Rohde LA, Borges MC, Tovo-Rodrigues L. Assessing causality in the association between attention-deficit/hyperactivity disorder and obesity: a Mendelian randomization study. Int J Obes (Lond) 2019;43:2500-8. [PMID: 31000774 DOI: 10.1038/s41366-019-0346-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
81 Evren C, Alniak I, Karabulut V, Cetin T, Umut G, Agachanli R, Evren B. Relationship of Probable Attention Deficit Hyperactivity Disorder with Severity of Psychopathology and Impulsivity in a Sample of Male Patients with Opioid Use Disorder. Psychiatry Investig 2018;15:164-71. [PMID: 29475216 DOI: 10.30773/pi.2017.05.14.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
82 van Wingen GA, van den Brink W, Veltman DJ, Schmaal L, Dom G, Booij J, Crunelle CL. Reduced striatal brain volumes in non-medicated adult ADHD patients with comorbid cocaine dependence. Drug and Alcohol Dependence 2013;131:198-203. [DOI: 10.1016/j.drugalcdep.2013.05.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
83 Aas CF, Vold JH, Gjestad R, Skurtveit S, Lim AG, Gjerde KV, Løberg EM, Johansson KA, Fadnes LT; INTRO-HCV Study Group. Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway. Subst Abuse Treat Prev Policy 2021;16:20. [PMID: 33639969 DOI: 10.1186/s13011-021-00354-1] [Reference Citation Analysis]
84 Yule AM, Wilens TE, Martelon M, Rosenthal L, Biederman J. Does exposure to parental substance use disorders increase offspring risk for a substance use disorder? A longitudinal follow-up study into young adulthood. Drug Alcohol Depend 2018;186:154-8. [PMID: 29573650 DOI: 10.1016/j.drugalcdep.2018.01.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
85 Li DJ, Chen YL, Chen YY, Hsiao RC, Lu WH, Yen CF. Increased Risk of Traumatic Injuries Among Parents of Children with Attention Deficit/Hyperactivity Disorder: A Nationwide Population-Based Study. Int J Environ Res Public Health 2021;18:3586. [PMID: 33808366 DOI: 10.3390/ijerph18073586] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Özgen H, Spijkerman R, Noack M, Holtmann M, Schellekens ASA, van de Glind G, Banaschewski T, Barta C, Begeman A, Casas M, Crunelle CL, Daigre Blanco C, Dalsgaard S, Demetrovics Z, den Boer J, Dom G, Eapen V, Faraone SV, Franck J, González RA, Grau-López L, Groenman AP, Hemphälä M, Icick R, Johnson B, Kaess M, Kapitány-Fövény M, Kasinathan JG, Kaye SS, Kiefer F, Konstenius M, Levin FR, Luderer M, Martinotti G, Matthys FIA, Meszaros G, Moggi F, Munasur-Naidoo AP, Post M, Rabinovitz S, Ramos-Quiroga JA, Sala R, Shafi A, Slobodin O, Staal WG, Thomasius R, Truter I, van Kernebeek MW, Velez-Pastrana MC, Vollstädt-Klein S, Vorspan F, Young JT, Yule A, van den Brink W, Hendriks V. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder]. Z Kinder Jugendpsychiatr Psychother 2021. [PMID: 34397296 DOI: 10.1024/1422-4917/a000828] [Reference Citation Analysis]
87 Crunelle CL, van den Brink W, Moggi F, Konstenius M, Franck J, Levin FR, van de Glind G, Demetrovics Z, Coetzee C, Luderer M, Schellekens A, Matthys F; ICASA consensus group. International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder. Eur Addict Res 2018;24:43-51. [PMID: 29510390 DOI: 10.1159/000487767] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 11.3] [Reference Citation Analysis]
88 Soeiro T, Frauger É, Pradel V, Micallef J. Doctor shopping for methylphenidate as a proxy for misuse and potential abuse in the 67 million inhabitants in France. Fundam Clin Pharmacol 2021;35:751-61. [PMID: 33025606 DOI: 10.1111/fcp.12612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
89 Tarver J, Daley D, Sayal K. Attention-deficit hyperactivity disorder (ADHD): an updated review of the essential facts: ADHD: an updated review of the essential facts. Child Care Health Dev 2014;40:762-74. [DOI: 10.1111/cch.12139] [Cited by in Crossref: 106] [Cited by in F6Publishing: 80] [Article Influence: 13.3] [Reference Citation Analysis]
90 Vilar‐ribó L, Sánchez‐mora C, Rovira P, Richarte V, Corrales M, Fadeuilhe C, Arribas L, Casas M, Ramos‐quiroga JA, Ribasés M, Soler Artigas M. Genetic overlap and causality between substance use disorder and attention‐deficit and hyperactivity disorder. Am J Med Genet 2021;186:140-50. [DOI: 10.1002/ajmg.b.32827] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Solmi F, Sonneville KR, Easter A, Horton NJ, Crosby RD, Treasure J, Rodriguez A, Jarvelin MR, Field AE, Micali N. Prevalence of purging at age 16 and associations with negative outcomes among girls in three community-based cohorts. J Child Psychol Psychiatry 2015;56:87-96. [PMID: 24975817 DOI: 10.1111/jcpp.12283] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
92 Kapitány-fövény M, Richman MJ, Demetrovics Z, Sulyok M. Do you let me symptomatize? The potential role of cultural values in cross-national variability of mental disorders’ prevalence. Int J Soc Psychiatry 2018;64:756-66. [DOI: 10.1177/0020764018811361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
93 Lohit SR, Babu GN, Sharma S, Rao S, Sachin BS, Matkar AV. Prevalence of Adult ADHD Co-morbidity in Alcohol Use Disorders in a General Hospital Setup. Indian J Psychol Med 2019;41:523-8. [PMID: 31772438 DOI: 10.4103/IJPSYM.IJPSYM_464_18] [Reference Citation Analysis]
94 Tardelli VS, Bisaga A, Arcadepani FB, Gerra G, Levin FR, Fidalgo TM. Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis. Psychopharmacology (Berl) 2020;237:2233-55. [PMID: 32601988 DOI: 10.1007/s00213-020-05563-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
95 Bolstad I, Lien L, Bramness JG. ADHD symptoms as risk factor for PTSD in inpatients treated for alcohol use disorder. Psychiatry Res 2021;300:113904. [PMID: 33872853 DOI: 10.1016/j.psychres.2021.113904] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Konstenius M, Leifman A, van Emmerik-van Oortmerssen K, van de Glind G, Franck J, Moggi F, Ramos-Quiroga JA, Levin FR, Carpentier PJ, Skutle A, Bu ET, Kaye S, Demetrovics Z, Barta C, Auriecomb M, Fatséas M, Johnson B, Faraone SV, Allsop S, Carruthers S, Schoevers RA, Verspreet S, Dom G, Koeter MW, van den Brink W. Childhood trauma exposure in substance use disorder patients with and without ADHD. Addict Behav 2017;65:118-24. [PMID: 27816036 DOI: 10.1016/j.addbeh.2016.10.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
97 Slobodin O, Crunelle CL. Mini Review: Socio-Cultural Influences on the Link Between ADHD and SUD. Front Public Health 2019;7:173. [PMID: 31294015 DOI: 10.3389/fpubh.2019.00173] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
98 Skutle A, Bu ETH, Jellestad FK, van Emmerik-van Oortmerssen K, Dom G, Verspreet S, Carpentier PJ, Ramos-Quiroga JA, Franck J, Konstenius M, Kaye S, Demetrovics Z, Barta C, Fatséas M, Auriacombe M, Johnson B, Faraone SV, Levin FR, Allsop S, Carruthers S, Schoevers RA, Koeter MWJ, van den Brink W, Moggi F, Møller M, van de Glind G. Early developmental, temperamental and educational problems in 'substance use disorder' patients with and without ADHD. Does ADHD make a difference? Addict Behav Rep 2015;2:13-8. [PMID: 29531989 DOI: 10.1016/j.abrep.2015.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
99 Vold JH, Gjestad R, Aas CF, Meland E, Johansson KA, Fadnes LT; INTRO-HCV Study Group. Validation of a three-item Fatigue Severity Scale for patients with substance use disorder: a cohort study from Norway for the period 2016-2020. Health Qual Life Outcomes 2021;19:69. [PMID: 33653349 DOI: 10.1186/s12955-021-01708-w] [Reference Citation Analysis]
100 Vold JH, Aas C, Skurtveit S, Odsbu I, Chalabianloo F, Reutfors J, Halmøy A, Johansson KA, Fadnes LT. Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017. BMJ Open 2020;10:e036860. [PMID: 32771988 DOI: 10.1136/bmjopen-2020-036860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
101 Liao YT, Chen CY, Ng MH, Huang KY, Shao WC, Lin TY, Chen VC, Gossop M. Depression and severity of substance dependence among heroin dependent patients with ADHD symptoms. Am J Addict 2017;26:26-33. [PMID: 27997065 DOI: 10.1111/ajad.12487] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
102 Childress AC, Beltran N, Supnet C, Weiss MD. Reviewing the role of emerging therapies in the ADHD armamentarium. Expert Opin Emerg Drugs 2021;26:1-16. [PMID: 33143485 DOI: 10.1080/14728214.2020.1846718] [Reference Citation Analysis]
103 Kast KA, Rao V, Wilens TE. Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder and Retention in Outpatient Substance Use Disorder Treatment: A Retrospective Cohort Study. J Clin Psychiatry 2021;82:20m13598. [PMID: 33988929 DOI: 10.4088/JCP.20m13598] [Reference Citation Analysis]
104 Palma-Álvarez RF, Barta C, Carpentier PJ, Carruthers S, Crunelle CL, Demetrovics Z, Dom G, Faraone SV, Franck J, Johnson B, Kapitány-Fövény M, Kaye S, Konstenius M, Matthys F, Moggi F, Møller M, Schellekens A, Skutle A, van de Glind G, van Emmerik-van Oortmerssen K, Verspreet S, Schoevers RA, Wallhed S, Levin FR, Grau-López L, Casas M, van den Brink W, Ramos-Quiroga JA; IASP Research Group. Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus. Rev Psiquiatr Salud Ment (Engl Ed) 2020:S1888-9891(20)30038-0. [PMID: 32561156 DOI: 10.1016/j.rpsm.2020.04.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Ginsberg Y, Beusterien KM, Amos K, Jousselin C, Asherson P. The unmet needs of all adults with ADHD are not the same: a focus on Europe. Expert Review of Neurotherapeutics 2014;14:799-812. [DOI: 10.1586/14737175.2014.926220] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
106 Bassiony MM, Salah El-Deen GM, Ameen N, Mahdy RS. Prevalence, correlates, and consequences of attention-deficit/hyperactivity disorder in a clinical sample of adults with tramadol use in Egypt. Am J Addict 2021. [PMID: 34608707 DOI: 10.1111/ajad.13231] [Reference Citation Analysis]
107 Capusan AJ, Bendtsen P, Marteinsdottir I, Larsson H. Comorbidity of Adult ADHD and Its Subtypes With Substance Use Disorder in a Large Population-Based Epidemiological Study. J Atten Disord. 2019;23:1416-1426. [PMID: 26838558 DOI: 10.1177/1087054715626511] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
108 Skoglund C, Brandt L, D'Onofrio B, Larsson H, Franck J. Methylphenidate doses in Attention Deficit/Hyperactivity Disorder and comorbid substance use disorders. Eur Neuropsychopharmacol 2017;27:1144-52. [PMID: 28935267 DOI: 10.1016/j.euroneuro.2017.08.435] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
109 Constantin E, Low NC, Dugas E, Karp I, O'Loughlin J. Association Between Childhood Sleep-Disordered Breathing and Disruptive Behavior Disorders in Childhood and Adolescence. Behav Sleep Med 2015;13:442-54. [PMID: 25102357 DOI: 10.1080/15402002.2014.940106] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
110 Luderer M, Ramos Quiroga JA, Faraone SV, Zhang James Y, Reif A. Alcohol use disorders and ADHD. Neurosci Biobehav Rev 2021;128:648-60. [PMID: 34265320 DOI: 10.1016/j.neubiorev.2021.07.010] [Reference Citation Analysis]
111 Deberdt W, Thome J, Lebrec J, Kraemer S, Fregenal I, Ramos-Quiroga JA, Arif M. Prevalence of ADHD in nonpsychotic adult psychiatric care (ADPSYC): A multinational cross-sectional study in Europe. BMC Psychiatry 2015;15:242. [PMID: 26462666 DOI: 10.1186/s12888-015-0624-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
112 Bihlar Muld B, Jokinen J, Bölte S, Hirvikoski T. Skills training groups for men with ADHD in compulsory care due to substance use disorder: a feasibility study. ADHD Atten Def Hyp Disord 2016;8:159-72. [DOI: 10.1007/s12402-016-0195-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
113 Cheng SH, Lee CT, Chi MH, Sun ZJ, Chen PS, Chang YF, Yeh CB, Yang YK, Yang YC. Factors Related to Self-Reported Attention Deficit Among Incoming University Students. J Atten Disord. 2016;20:754-762. [PMID: 25270565 DOI: 10.1177/1087054714550335] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
114 Grimm O, Kittel-Schneider S, Reif A. Recent developments in the genetics of attention-deficit hyperactivity disorder. Psychiatry Clin Neurosci 2018;72:654-72. [PMID: 29722101 DOI: 10.1111/pcn.12673] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
115 Seitz A, Wapp M, Burren Y, Stutz S, Schläfli K, Moggi F. Association between Craving and Attention Deficit/Hyperactivity Disorder Symptoms among Patients with Alcohol Use Disorders: Alcohol Craving and ADHD Symptoms. Am J Addict 2013;22:292-6. [DOI: 10.1111/j.1521-0391.2012.12000.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
116 Van de Glind G, Brynte C, Skutle A, Kaye S, Konstenius M, Levin F, Mathys F, Demetrovics Z, Moggi F, Ramos-Quiroga JA, Schellekens A, Crunelle C, Dom G, van den Brink W, Franck J. The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future Activities. Eur Addict Res 2020;26:173-8. [PMID: 32599579 DOI: 10.1159/000508870] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
117 Castillo-Carniglia A, Keyes KM, Hasin DS, Cerdá M. Psychiatric comorbidities in alcohol use disorder. Lancet Psychiatry 2019;6:1068-80. [PMID: 31630984 DOI: 10.1016/S2215-0366(19)30222-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 10.7] [Reference Citation Analysis]
118 Aas CF, Vold JH, Skurtveit S, Lim AG, Ruths S, Islam K, Askildsen JE, Løberg EM, Fadnes LT, Johansson KA; INTRO-HCV Study Group. Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway. Subst Abuse Treat Prev Policy 2020;15:68. [PMID: 32883319 DOI: 10.1186/s13011-020-00309-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
119 Young S, González RA, Mutch L, Mallet-Lambert I, O'Rourke L, Hickey N, Asherson P, Gudjonsson GH. Diagnostic accuracy of a brief screening tool for attention deficit hyperactivity disorder in UK prison inmates. Psychol Med 2016;46:1449-58. [PMID: 26867860 DOI: 10.1017/S0033291716000039] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
120 Luo SX, Levin FR. Towards Precision Addiction Treatment: New Findings in Co-morbid Substance Use and Attention-Deficit Hyperactivity Disorders. Curr Psychiatry Rep 2017;19:14. [PMID: 28251590 DOI: 10.1007/s11920-017-0769-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
121 Dullur P, Krishnan V, Diaz AM. A systematic review on the intersection of attention-deficit hyperactivity disorder and gaming disorder. J Psychiatr Res 2021;133:212-22. [PMID: 33360866 DOI: 10.1016/j.jpsychires.2020.12.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
122 Kronenberg LM, Goossens PJ, van Etten DM, van Achterberg T, van den Brink W. Need for care and life satisfaction in adult substance use disorder patients with and without attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). Perspect Psychiatr Care 2015;51:4-15. [PMID: 24410895 DOI: 10.1111/ppc.12056] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
123 Spera V, Pallucchini A, Carli M, Maiello M, Maremmani AGI, Perugi G, Maremmani I. Does Cannabis, Cocaine and Alcohol Use Impact Differently on Adult Attention Deficit/Hyperactivity Disorder Clinical Picture? J Clin Med 2021;10:1481. [PMID: 33918432 DOI: 10.3390/jcm10071481] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
124 Silbernagl M, Yanagida T, Slamanig R, Fischer G, Brandt L. Comorbidity Patterns Among Patients With Opioid Use Disorder and Problem Gambling: ADHD Status Predicts Class Membership. J Dual Diagn 2019;15:147-58. [PMID: 30999811 DOI: 10.1080/15504263.2019.1590672] [Reference Citation Analysis]
125 Liebrenz M, Gamma A, Ivanov I, Buadze A, Eich D. Adult attention-deficit/hyperactivity disorder: Associations between subtype and lifetime substance use - a clinical study. F1000Res 2015;4:407. [PMID: 27853503 DOI: 10.12688/f1000research.6780.2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
126 Pallucchini A, Carli M, Scarselli M, Maremmani I, Perugi G. Symptomatological Variants and Related Clinical Features in Adult Attention Deficit Hyperactive Disorder. Int J Environ Res Public Health 2021;18:922. [PMID: 33494421 DOI: 10.3390/ijerph18030922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Tamburin S, Federico A, Morbioli L, Faccini M, Casari R, Zamboni L, Briguglio G, Lugoboni F. Screening for adult attention deficit/hyperactivity disorder in high-dose benzodiazepine dependent patients: ADHD in High-Dose BZD Dependent Patients. Am J Addict 2017;26:610-4. [DOI: 10.1111/ajad.12573] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
128 Evren C, Dalbudak E, Evren B, Can Y, Umut G. The severity of attention deficit hyperactivity symptoms and its relationship with lifetime substance use and psychological variables among 10th grade students in Istanbul. Compr Psychiatry. 2014;55:1665-1670. [PMID: 25015303 DOI: 10.1016/j.comppsych.2014.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
129 Young S, González RA, Wolff K, Mutch L, Malet-lambert I, Gudjonsson GH. Transitions and Motivations for Substance Misuse in Prison Inmates With ADHD and Conduct Disorder: Validation of a New Instrument. Journal of Dual Diagnosis 2017;13:91-100. [DOI: 10.1080/15504263.2017.1290859] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
130 Saleh A, Fuchs C, Taylor WD, Niarhos F. Evaluating the consistency of scales used in adult attention deficit hyperactivity disorder assessment of college-aged adults. J Am Coll Health 2018;66:98-105. [PMID: 28915090 DOI: 10.1080/07448481.2017.1377206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
131 Shanks RA, Ross JM, Doyle HH, Helton AK, Picou BN, Schulz J, Tavares C, Bryant S, Dawson BL, Lloyd SA. Adolescent exposure to cocaine, amphetamine, and methylphenidate cross-sensitizes adults to methamphetamine with drug- and sex-specific effects. Behav Brain Res 2015;281:116-24. [PMID: 25496784 DOI: 10.1016/j.bbr.2014.12.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
132 Farré‐colomés À, Gerhardt S, Luderer M, Sobanski E, Kiefer F, Vollstädt‐klein S. Common and distinct neural connectivity in attention‐deficit/hyperactivity disorder and alcohol use disorder studied using resting‐state functional magnetic resonance imaging. Alcohol Clin Exp Res 2021;45:948-60. [DOI: 10.1111/acer.14593] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Vold JH, Skurtveit S, Aas C, Johansson KA, Fadnes LT. Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013-2017): a prospective cohort study. BMC Health Serv Res 2020;20:668. [PMID: 32690022 DOI: 10.1186/s12913-020-05504-y] [Reference Citation Analysis]
134 Bihlar Muld B, Jokinen J, Bölte S, Hirvikoski T. Attention deficit/hyperactivity disorders with co-existing substance use disorder is characterized by early antisocial behaviour and poor cognitive skills. BMC Psychiatry 2013;13:336. [PMID: 24330331 DOI: 10.1186/1471-244X-13-336] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
135 van Emmerik-van Oortmerssen K, Vedel E, Kramer FJ, Koeter MW, Schoevers RA, van den Brink W. Diagnosing ADHD during active substance use: Feasible or flawed? Drug Alcohol Depend 2017;180:371-5. [PMID: 28957778 DOI: 10.1016/j.drugalcdep.2017.07.039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
136 van Emmerik-van Oortmerssen K, Vedel E, Kramer FJ, Blankers M, Dekker JJ, van den Brink W, Schoevers RA. Integrated cognitive behavioral therapy for ADHD in adult substance use disorder patients: Results of a randomized clinical trial. Drug and Alcohol Dependence 2019;197:28-36. [DOI: 10.1016/j.drugalcdep.2018.12.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
137 Ginsberg Y, Quintero J, Anand E, Casillas M, Upadhyaya HP. Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature. Prim Care Companion CNS Disord 2014;16:PCC. [PMID: 25317367 DOI: 10.4088/PCC.13r01600] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
138 Bron TI, Bijlenga D, Breuk M, Michielsen M, Beekman AT, ​Kooij JS. Risk factors for adverse driving outcomes in Dutch adults with ADHD and controls. Accident Analysis & Prevention 2018;111:338-44. [DOI: 10.1016/j.aap.2017.12.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
139 Ramos-quiroga JA, Nasillo V, Fernández-aranda F, Casas M. Addressing the lack of studies in attention-deficit/hyperactivity disorder in adults. Expert Review of Neurotherapeutics 2014;14:553-67. [DOI: 10.1586/14737175.2014.908708] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
140 Perugi G, Pallucchini A, Rizzato S, De Rossi P, Sani G, Maremmani AG, Pinzone V, Maremmani I. Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (SUD). Expert Opin Pharmacother 2019;20:343-55. [PMID: 30513231 DOI: 10.1080/14656566.2018.1551878] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
141 Regan T, Tubman J. Attention Deficit Hyperactivity Disorder (ADHD) Subtypes, Co-Occurring Psychiatric Symptoms and Sexual Risk Behaviors among Adolescents Receiving Substance Abuse Treatment. Subst Use Misuse 2020;55:119-32. [PMID: 31502500 DOI: 10.1080/10826084.2019.1657895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
142 Caprioli D, Hong YT, Sawiak SJ, Ferrari V, Williamson DJ, Jupp B, Adrian Carpenter T, Aigbirhio FI, Everitt BJ, Robbins TW, Fryer TD, Dalley JW. Baseline-dependent effects of cocaine pre-exposure on impulsivity and D2/3 receptor availability in the rat striatum: possible relevance to the attention-deficit hyperactivity syndrome. Neuropsychopharmacology 2013;38:1460-71. [PMID: 23399948 DOI: 10.1038/npp.2013.44] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
143 Young S, Woodhouse E. Assessment and treatment of substance use in adults with ADHD: a psychological approach. J Neural Transm (Vienna) 2021;128:1099-108. [PMID: 33211196 DOI: 10.1007/s00702-020-02277-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
144 Bitter I, Angyalosi A, Czobor P. Pharmacological treatment of adult ADHD. Current Opinion in Psychiatry 2012;25:529-34. [DOI: 10.1097/yco.0b013e328356f87f] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
145 Young S, González RA, Wolff K, Xenitidis K, Mutch L, Malet-lambert I, Gudjonsson GH. Substance and Alcohol Misuse, Drug Pathways, and Offending Behaviors in Association With ADHD in Prison Inmates. J Atten Disord 2020;24:1905-13. [DOI: 10.1177/1087054716688532] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
146 Paraskevopoulou M, van Rooij D, Schene AH, Chauvin R, Buitelaar JK, Schellekens AFA. Effects of substance misuse on inhibitory control in patients with attention-deficit/hyperactivity disorder. Addict Biol 2021;:e13063. [PMID: 34101312 DOI: 10.1111/adb.13063] [Reference Citation Analysis]
147 Altınöz AE, Aslan S, Uğurlu M, Özdel K, Sargın AE, Türkçapar MH. Measuring the beliefs on alcohol craving by using craving beliefs questionnaire: preliminary results of its psychometric properties in a Turkish sample. Journal of Substance Use 2016;21:455-9. [DOI: 10.3109/14659891.2015.1056852] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
148 Jackson JN, MacKillop J. Attention-Deficit/Hyperactivity Disorder and Monetary Delay Discounting: A Meta-Analysis of Case-Control Studies. Biol Psychiatry Cogn Neurosci Neuroimaging 2016;1:316-25. [PMID: 27722208 DOI: 10.1016/j.bpsc.2016.01.007] [Cited by in Crossref: 42] [Cited by in F6Publishing: 52] [Article Influence: 7.0] [Reference Citation Analysis]
149 Liebrenz M, Gamma A, Ivanov I, Buadze A, Eich D. Adult attention-deficit/hyperactivity disorder: Associations between subtype and lifetime substance use - a clinical study. F1000Res 2015;4:407. [PMID: 27853503 DOI: 10.12688/f1000research.6780.2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
150 Cawkwell PB, Hong DS, Leikauf JE. Neurodevelopmental Effects of Cannabis Use in Adolescents and Emerging Adults with ADHD: A Systematic Review. Harv Rev Psychiatry 2021;29:251-61. [PMID: 34138796 DOI: 10.1097/HRP.0000000000000303] [Reference Citation Analysis]
151 Kaye S, Gilsenan J, Young JT, Carruthers S, Allsop S, Degenhardt L, van de Glind G, van den Brink W. Risk behaviours among substance use disorder treatment seekers with and without adult ADHD symptoms. Drug and Alcohol Dependence 2014;144:70-7. [DOI: 10.1016/j.drugalcdep.2014.08.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
152 Silang K, Sanguino H, Sohal PR, Rioux C, Kim HS, Tomfohr-Madsen LM. eHealth Interventions to Treat Substance Use in Pregnancy: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health 2021;18:9952. [PMID: 34639252 DOI: 10.3390/ijerph18199952] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
153 Skoglund C, Chen Q, Franck J, Lichtenstein P, Larsson H. Attention-deficit/hyperactivity disorder and risk for substance use disorders in relatives. Biol Psychiatry 2015;77:880-6. [PMID: 25457227 DOI: 10.1016/j.biopsych.2014.10.006] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
154 Bozkurt M, Evren C, Umut G, Evren B. Relationship of attention-deficit/hyperactivity disorder symptom severity with severity of alcohol-related problems in a sample of inpatients with alcohol use disorder. Neuropsychiatr Dis Treat 2016;12:1661-7. [PMID: 27462159 DOI: 10.2147/NDT.S105190] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
155 Matthys F, Joostens P, Stes S, Tremmery S, Sabbe B. The Construction of the First Validated (Evidence Based) Guideline for Dual Diagnosis of ADHD and SUD; Data from Focus Groups. Int J Ment Health Addiction 2013;11:557-67. [DOI: 10.1007/s11469-013-9438-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
156 Garcia M, Rouchy E, Galéra C, Tzourio C, Michel G. The relation between ADHD symptoms, perceived stress and binge drinking in college students. Psychiatry Research 2020;284:112689. [DOI: 10.1016/j.psychres.2019.112689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Sánchez-mora C, Ramos-quiroga J, Garcia-martínez I, Fernàndez-castillo N, Bosch R, Richarte V, Palomar G, Nogueira M, Corrales M, Daigre C, Martínez-luna N, Grau-lopez L, Toma C, Cormand B, Roncero C, Casas M, Ribasés M. Evaluation of single nucleotide polymorphisms in the miR-183–96–182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs). European Neuropsychopharmacology 2013;23:1463-73. [DOI: 10.1016/j.euroneuro.2013.07.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
158 Desai M, Bandawar M, Kandasamy A, Benegal V. Family Loading and Morbidity Risk of Attention-deficit Hyperactivity Disorder in Patients with Alcohol-dependence Syndrome. Indian J Psychol Med 2017;39:659-62. [PMID: 29200564 DOI: 10.4103/IJPSYM.IJPSYM_263_17] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
159 Carpentier PJ, Levin FR. Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us? Harv Rev Psychiatry 2017;25:50-64. [PMID: 28272130 DOI: 10.1097/HRP.0000000000000122] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
160 Amen DG, Henderson TA, Newberg A. SPECT Functional Neuroimaging Distinguishes Adult Attention Deficit Hyperactivity Disorder From Healthy Controls in Big Data Imaging Cohorts. Front Psychiatry 2021;12:725788. [PMID: 34899414 DOI: 10.3389/fpsyt.2021.725788] [Reference Citation Analysis]
161 Dahlman D, Abrahamsson T, Kral AH, Hakansson A. Nonmedical Use of Antihistaminergic Anxiolytics and Other Prescription Drugs among Persons with Opioid Dependence. J Addict 2016;2016:9298571. [PMID: 28097037 DOI: 10.1155/2016/9298571] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
162 Kaye S, Darke S, Torok M. Attention deficit hyperactivity disorder (ADHD) among illicit psychostimulant users: a hidden disorder?: ADHD among illicit psychostimulant users. Addiction 2013;108:923-31. [DOI: 10.1111/add.12086] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
163 El Ayoubi H, Barrault S, Gateau A, Cortese S, Frammery J, Mollat E, Bonnet-Brilhault F, Grall-Bronnec M, Ballon N, Brunault P. Adult attention-deficit/hyperactivity disorder among alcohol use disorder inpatients is associated with food addiction and binge eating, but not BMI. Appetite 2021;168:105665. [PMID: 34455024 DOI: 10.1016/j.appet.2021.105665] [Reference Citation Analysis]
164 Novi M, Paraskevopoulou M, Van Rooij D, Schene AH, Buitelaar JK, Schellekens AFA. Effects of substance misuse and current family history of substance use disorder on brain structure in adolescents and young adults with attention-deficit/hyperactivity disorder. Drug Alcohol Depend 2021;228:109032. [PMID: 34555690 DOI: 10.1016/j.drugalcdep.2021.109032] [Reference Citation Analysis]
165 Vonmoos M, Hulka LM, Preller KH, Jenni D, Schulz C, Baumgartner MR, Quednow BB. Differences in self-reported and behavioral measures of impulsivity in recreational and dependent cocaine users. Drug and Alcohol Dependence 2013;133:61-70. [DOI: 10.1016/j.drugalcdep.2013.05.032] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
166 Levin FR, Mariani JJ, Specker S, Mooney M, Mahony A, Brooks DJ, Babb D, Bai Y, Eberly LE, Nunes EV, Grabowski J. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry 2015;72:593-602. [PMID: 25887096 DOI: 10.1001/jamapsychiatry.2015.41] [Cited by in Crossref: 80] [Cited by in F6Publishing: 63] [Article Influence: 11.4] [Reference Citation Analysis]
167 Coetzee C, Truter I, Meyer A. Prevalence and characteristics of South African treatment-seeking patients with substance use disorder and co-occurring attention-deficit/hyperactivity disorder. Expert Rev Clin Pharmacol 2020;13:1271-80. [PMID: 33040639 DOI: 10.1080/17512433.2020.1835467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
168 Kronenberg LM, Goossens PJ, van Busschbach J, van Achterberg T, van den Brink W. Coping styles in substance use disorder (SUD) patients with and without co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). BMC Psychiatry 2015;15:159. [PMID: 26169586 DOI: 10.1186/s12888-015-0530-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
169 Van Hout MC, Foley M. Attention-deficit hyperactivity disorder (ADHD) in adults attending addiction treatment in Ireland: preliminary international ADHD in substance-use disorders prevalence study (IASP) results. Ir J Psychol Med 2013;30:171-7. [PMID: 30189493 DOI: 10.1017/ipm.2013.8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
170 Broos N, van Mourik Y, Schetters D, De Vries TJ, Pattij T. Dissociable effects of cocaine and yohimbine on impulsive action and relapse to cocaine seeking. Psychopharmacology (Berl) 2017;234:3343-51. [PMID: 28856391 DOI: 10.1007/s00213-017-4711-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
171 Kronenberg LM, Slager-Visscher K, Goossens PJ, van den Brink W, van Achterberg T. Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): a patient's perspective. BMC Psychiatry 2014;14:264. [PMID: 25234344 DOI: 10.1186/s12888-014-0264-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
172 Waller R, Murray L, Shaw DS, Forbes EE, Hyde LW. Accelerated alcohol use across adolescence predicts early adult symptoms of alcohol use disorder via reward-related neural function. Psychol Med 2019;49:675-84. [PMID: 29871712 DOI: 10.1017/S003329171800137X] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
173 Spera V, Pallucchini A, Maiello M, Carli M, Maremmani AGI, Perugi G, Maremmani I. Substance Use Disorder in Adult-Attention Deficit Hyperactive Disorder Patients: Patterns of Use and Related Clinical Features. Int J Environ Res Public Health 2020;17:E3509. [PMID: 32429586 DOI: 10.3390/ijerph17103509] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
174 Young S, Cocallis KM. Attention Deficit Hyperactivity Disorder (ADHD) in the Prison System. Curr Psychiatry Rep 2019;21. [DOI: 10.1007/s11920-019-1022-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
175 Castells X, Cunill R, Pérez-Mañá C, Vidal X, Capellà D. Psychostimulant drugs for cocaine dependence. Cochrane Database Syst Rev 2016;9:CD007380. [PMID: 27670244 DOI: 10.1002/14651858.CD007380.pub4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
176 Banzer R, Haring C, Buchheim A, Oehler S, Carli V, Wasserman C, Kaess M, Apter A, Balazs J, Bobes J, Brunner R, Corcoran P, Cosman D, Hoven CW, Kahn JP, Keeley HS, Postuvan V, Podlogar T, Sisask M, Värnik A, Sarchiapone M, Wasserman D. Factors associated with different smoking status in European adolescents: results of the SEYLE study. Eur Child Adolesc Psychiatry 2017;26:1319-29. [PMID: 28386649 DOI: 10.1007/s00787-017-0980-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
177 Adamis D, Graffeo I, Kumar R, Meagher D, O'Neill D, Mulligan O, Murthy S, O'Mahony E, McCarthy G, Gavin B, McNicholas F. Screening for attention deficit-hyperactivity disorder (ADHD) symptomatology in adult mental health clinics. Ir J Psychol Med 2018;35:193-201. [PMID: 30124183 DOI: 10.1017/ipm.2017.49] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
178 So R, Makino K, Fujiwara M, Hirota T, Ohcho K, Ikeda S, Tsubouchi S, Inagaki M. The Prevalence of Internet Addiction Among a Japanese Adolescent Psychiatric Clinic Sample With Autism Spectrum Disorder and/or Attention-Deficit Hyperactivity Disorder: A Cross-Sectional Study. J Autism Dev Disord 2017;47:2217-24. [PMID: 28474226 DOI: 10.1007/s10803-017-3148-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
179 Lövenhag S, Larm P, Åslund C, Nilsson KW. Antisocial behavior reduces the association between subdimensions of ADHD symptoms and alcohol use in a large population-based sample of adolescents. Scand J Psychol 2015;56:489-97. [PMID: 26094652 DOI: 10.1111/sjop.12234] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
180 Young S, Cocallis K. ADHD and offending. J Neural Transm (Vienna) 2021;128:1009-19. [PMID: 33538909 DOI: 10.1007/s00702-021-02308-0] [Reference Citation Analysis]
181 Wunderli MD, Vonmoos M, Niedecker SM, Hulka LM, Preller KH, Baumgartner MR, Kraemer T, Seifritz E, Schaub MP, Eich-Höchli D, Quednow BB. Cognitive and emotional impairments in adults with attention-deficit/hyperactivity disorder and cocaine use. Drug Alcohol Depend 2016;163:92-9. [PMID: 27085500 DOI: 10.1016/j.drugalcdep.2016.03.026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
182 Huang H, Huang H, Spottswood M, Ghaemi N. Approach to Evaluating and Managing Adult Attention-Deficit/Hyperactivity Disorder in Primary Care. Harv Rev Psychiatry 2020;28:100-6. [DOI: 10.1097/hrp.0000000000000248] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
183 Kronenberg LM, Verkerk-Tamminga R, Goossens PJ, van den Brink W, van Achterberg T. Personal recovery in individuals diagnosed with substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). Arch Psychiatr Nurs 2015;29:242-8. [PMID: 26165980 DOI: 10.1016/j.apnu.2015.04.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
184 Costa MDLP, Oliveira LCMD. Comorbidities of mental and behavioral disorders in chemically dependent patients in different periods of abstinence. J bras psiquiatr 2012;61:139-47. [DOI: 10.1590/s0047-20852012000300004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
185 Gerhardt S, Luderer M, Bumb JM, Sobanski E, Moggi F, Kiefer F, Vollstädt-Klein S. Stop What You're Doing!-An fMRI Study on Comparisons of Neural Subprocesses of Response Inhibition in ADHD and Alcohol Use Disorder. Front Psychiatry 2021;12:691930. [PMID: 34603097 DOI: 10.3389/fpsyt.2021.691930] [Reference Citation Analysis]
186 Kaye S, Ramos-Quiroga JA, van de Glind G, Levin FR, Faraone SV, Allsop S, Degenhardt L, Moggi F, Barta C, Konstenius M, Franck J, Skutle A, Bu ET, Koeter MWJ, Demetrovics Z, Kapitány-Fövény M, Schoevers RA, van Emmerik-van Oortmerssen K, Carpentier PJ, Dom G, Verspreet S, Crunelle CL, Young JT, Carruthers S, Cassar J, Fatséas M, Auriacombe M, Johnson B, Dunn M, Slobodin O, van den Brink W. Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment Seekers. J Atten Disord 2019;23:1438-53. [PMID: 26922805 DOI: 10.1177/1087054716629217] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
187 Bastiaens L, Galus J. Comparison of the Adult ADHD Self Report Scale Screener for DSM-IV and DSM-5 in a Dually Diagnosed Correctional Population. Psychiatr Q 2018;89:505-10. [PMID: 29270886 DOI: 10.1007/s11126-017-9553-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
188 Kronenberg LM, Goossens PJ, van Busschbach JT, van Achterberg T, van den Brink W. Burden and Expressed Emotion of Caregivers in Cases of Adult Substance Use Disorder with and Without Attention Deficit/Hyperactivity Disorder or Autism Spectrum Disorder. Int J Ment Health Addict 2016;14:49-63. [PMID: 26798327 DOI: 10.1007/s11469-015-9567-9] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
189 Horsager C, Faerk E, Lauritsen MB, Østergaard SD. Food addiction comorbid to mental disorders: A nationwide survey and register-based study. Int J Eat Disord 2021;54:545-60. [PMID: 33458821 DOI: 10.1002/eat.23472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
190 Kim S, Kim D. Behavioral symptoms of child mental disorders and lifetime substance use in adolescence: A within-family comparison of US siblings. Drug Alcohol Depend 2021;219:108490. [PMID: 33385692 DOI: 10.1016/j.drugalcdep.2020.108490] [Reference Citation Analysis]
191 Horsager C, Færk E, Gearhardt AN, Østergaard SD, Lauritsen MB. Validation of the dimensional Yale Food Addiction Scale for Children 2.0 and estimation of the weighted food addiction score in a sample of adolescents from the general population. Eat Weight Disord 2021. [PMID: 33550576 DOI: 10.1007/s40519-021-01113-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
192 Brancati GE, Barbuti M, Schiavi E, Colombini P, Moriconi M, Pallucchini A, Maiello M, Menculini G, Perugi G. Comparison of Emotional Dysregulation Features in Cyclothymia and Adult ADHD. Medicina (Kaunas) 2021;57:489. [PMID: 34066126 DOI: 10.3390/medicina57050489] [Reference Citation Analysis]
193 van Emmerik-van Oortmerssen K, Blankers M, Vedel E, Kramer F, Goudriaan AE, van den Brink W, Schoevers RA. Prediction of drop-out and outcome in integrated cognitive behavioral therapy for ADHD and SUD: Results from a randomized clinical trial. Addictive Behaviors 2020;103:106228. [DOI: 10.1016/j.addbeh.2019.106228] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
194 Björk A, Rönngren Y, Selander J, Vinberg S, Hellzen O, Olofsson N. Health, lifestyle habits, and physical fitness among adults with ADHD compared with a random sample of a Swedish general population. Society, Health & Vulnerability 2018;9:1553916. [DOI: 10.1080/20021518.2018.1553916] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
195 Oliva F, Mangiapane C, Nibbio G, Berchialla P, Colombi N, Vigna-taglianti F. Prevalence of cocaine use and cocaine use disorder among adult patients with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. Journal of Psychiatric Research 2020. [DOI: 10.1016/j.jpsychires.2020.11.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
196 Raffi ER, Gray J, Conteh N, Kane M, Cohen LS, Schiff DM. Low barrier perinatal psychiatric care for patients with substance use disorder: meeting patients across the perinatal continuum where they are. Int Rev Psychiatry 2021;33:543-52. [PMID: 34406106 DOI: 10.1080/09540261.2021.1898351] [Reference Citation Analysis]
197 Pérez de los Cobos J, Siñol N, Pérez V, Trujols J. Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction. Br J Clin Pharmacol 2014;77:337-56. [PMID: 23216449 DOI: 10.1111/bcp.12045] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
198 Yule AM, Martelon M, Faraone SV, Carrellas N, Wilens TE, Biederman J. Examining the association between attention deficit hyperactivity disorder and substance use disorders: A familial risk analysis. J Psychiatr Res 2017;85:49-55. [PMID: 27835739 DOI: 10.1016/j.jpsychires.2016.10.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
199 Evren C, Umut G, Bozkurt M, Can Y, Evren B, Agachanli R. Partial mediator role of physical abuse on the relationship between attention-deficit/hyperactivity disorder symptoms and severity of dissociative experiences in a sample of inpatients with alcohol use disorder. Indian J Psychiatry 2017;59:306-12. [PMID: 29085089 DOI: 10.4103/psychiatry.IndianJPsychiatry_366_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
200 Bejerot S, Humble MB. Childhood clumsiness and peer victimization: a case-control study of psychiatric patients. BMC Psychiatry 2013;13:68. [PMID: 23442984 DOI: 10.1186/1471-244X-13-68] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
201 Levin FR, Choi CJ, Pavlicova M, Mariani JJ, Mahony A, Brooks DJ, Nunes EV, Grabowski J. How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis. Drug Alcohol Depend 2018;188:135-40. [PMID: 29775957 DOI: 10.1016/j.drugalcdep.2018.03.043] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
202 Cole J, Sprang G, Silman M. Interpersonal Trauma Exposure, Trauma Symptoms, and Severity of Substance Use Disorder among Youth Entering Outpatient Substance Abuse Treatment. J Child Adolesc Trauma 2019;12:341-9. [PMID: 32318204 DOI: 10.1007/s40653-018-0239-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
203 Daurio AM, Aston SA, Schwandt ML, Bukhari MO, Bouhlal S, Farokhnia M, Lee MR, Leggio L. Impulsive Personality Traits Mediate the Relationship Between Adult Attention-Deficit/Hyperactivity Symptoms and Alcohol Dependence Severity. Alcohol Clin Exp Res 2018;42:173-83. [PMID: 29063627 DOI: 10.1111/acer.13538] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
204 Hagen E, Erga AH, Nesvåg SM, McKay JR, Lundervold AJ, Walderhaug E. One-year abstinence improves ADHD symptoms among patients with polysubstance use disorder. Addict Behav Rep 2017;6:96-101. [PMID: 29450242 DOI: 10.1016/j.abrep.2017.08.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
205 Grimm O, van Rooij D, Hoogman M, Klein M, Buitelaar J, Franke B, Reif A, Plichta MM. Transdiagnostic neuroimaging of reward system phenotypes in ADHD and comorbid disorders. Neurosci Biobehav Rev 2021;128:165-81. [PMID: 34144113 DOI: 10.1016/j.neubiorev.2021.06.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
206 Pauly V, Frauger E, Lepelley M, Mallaret M, Boucherie Q, Micallef J. Patterns and profiles of methylphenidate use both in children and adults. Br J Clin Pharmacol 2018;84:1215-27. [PMID: 29512177 DOI: 10.1111/bcp.13544] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
207 Baggio S, Baudat S, Daeppen JB, Gmel G, Heller P, Perroud N, Rothen S, Sporkert F, Studer J, Wolff H, Iglesias K. Screening for alcohol use disorder among individuals with comorbid psychiatric disorders: Diagnostic accuracy in a sample of young Swiss men. Addict Behav 2020;106:106354. [PMID: 32135396 DOI: 10.1016/j.addbeh.2020.106354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
208 Bihlar Muld B, Jokinen J, Bölte S, Hirvikoski T. Long-Term Outcomes of Pharmacologically Treated Versus Non-Treated Adults with ADHD and Substance Use Disorder: A Naturalistic Study. Journal of Substance Abuse Treatment 2015;51:82-90. [DOI: 10.1016/j.jsat.2014.11.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]